• Increased efficacy
    Decreased toxicity
    Therapeutics ENHANCED

    Learn more

  • Drug-agnostic delivery platform
    No drug reformulation
    Active Partnering Programme

    Learn more

  • Tackling the toughest cancers
    Pipeline of ground-breaking therapies

    Learn more
123

About OxSonics®

OxSonics Therapeutics’ proprietary platform technology SonoTran®, has been developed to enable a step-change in the therapeutic index of anti-cancer agents without the development costs or delays associated with drug reformulation.

Find out how SonoTran works

Latest News

Events